Aadi Bioscience, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ACRV
|
Acrivon Therapeutics, Inc. Common Stock | $6.52 | $223.86 M | -2.51 | 58 | $0 |
 ADAG
|
Adagene Inc. | $2.19 | $131.46 M | -6.77 | 174 | $18.11 M |
 ANAB
|
AnaptysBio, Inc. | $22.26 | $640.07 M | -3.82 | 117 | $17.16 M |
 ANEB
|
Anebulo Pharmaceuticals, Inc. | $1.52 | $56.28 M | -5.86 | 2 | $0 |
 ANTX
|
AN2 Therapeutics, Inc. | $1.35 | $60.55 M | -0.81 | 41 | $0 |
 ARVN
|
Arvinas, Inc. | $25.85 | $1.83 B | -4.41 | 445 | $78.50 M |
 AVTE
|
Aerovate Therapeutics, Inc. | $2.67 | $597.48 M | -6.84 | 51 | $0 |
 CRNX
|
Crinetics Pharmaceuticals, Inc. | $56.02 | $3.53 B | -11.86 | 290 | $4.01 M |
 DSGN
|
Design Therapeutics, Inc. | $5.61 | $217.51 M | -3.7 | 54 | $0 |
 ERAS
|
Erasca, Inc. | $2.69 | $647.94 M | -2.83 | 126 | $0 |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $8.49 | $243.38 M | -1.59 | 133 | $0 |
 GRCL
|
Gracell Biotechnologies Inc. | $10.25 | $989.87 M | -10.57 | 314 | $0 |
 KURA
|
Kura Oncology, Inc. | $10.79 | $1.66 B | -10.03 | 142 | $0 |
 MLYS
|
Mineralys Therapeutics, Inc. | $12.49 | $652.38 M | -6.03 | 28 | $0 |
 RARE
|
Ultragenyx Pharmaceutical Inc. | $47.20 | $3.44 B | -5.21 | 1276 | $434.25 M |
 RVMD
|
Revolution Medicines, Inc. | $56.71 | $6.66 B | -10.51 | 490 | $11.58 M |
 RZLT
|
Rezolute, Inc. | $4.91 | $229.57 M | -5.02 | 59 | $0 |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |